French drugmaker Sanofi is launching an AI agent to support its field reps as life sciences companies continue to ramp up their use of next-generation technology across their businesses. More: Sanofi taps Snowflake for AI field agent help Source: fierce
read moreAs governments and health authorities rush to meet the moment of a worsening Ebola outbreak in central Africa, Merck & Co. is considering dusting off its antiviral molnupiravir, which saw use as a treatment for COVID-19 under an emergency use
read morePresident Donald Trump has endorsed a decision by the Department of Health and Human Services to cut down the number of required vaccinations for children, directing federal agencies to align their policies with HHS’ assessment. More: Trump signs off on
read moreAfter a prior misfire in demonstrating its protease inhibitor ensitrelvir’s potential as a COVID-19 treatment for U.S. patients, Shionogi has secured an FDA green light for the medicine in the prevention setting. More: Shionogi's COVID antiviral Xocova passes muster with
read moreHER2 combination strategies are evolving. Hear how biology and next-generation antibodies are redefining treatment. More: How HER2 biology is shaping next-generation cancer treatment Source: fierce
read moreViiV Healthcare is teaming up with TV personality, HIV and LGBTQ advocate Michelle Visage to help broaden awareness about new, longer-acting medicines that can significantly reduce the risk of HIV exposure. More: ViiV Healthcare launches ‘PrEP Wisdom’ campaign to boost
read more© 1994 - 2026 B.M. Pharmaceuticals